Bladder Cancer Carcinogens: Opportunities for Risk Reduction-Reference-Cited by-同舟云学术

Bladder Cancer Carcinogens: Opportunities for Risk Reduction

Published:2023-07 Issue:4 Volume:9 Page:575-578
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Gaffney Christopher D.,Katims Andrew,D'Souza Neeta,Bjurlin Marc A.,Matulewicz Richard S.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. Bjurlin MA, Matulewicz RS, editors. Comprehensive diagnostic approach to bladder cancer: molecular imaging and biomarkers. Cham, Switzerland: Springer International Publishing; 2021. https://doi.org/10.1007/978-3-030-82048-0.

2. Carcinogenic biomarkers of exposure in the urine of heated tobacco product users associated with bladder cancer: a systematic review;Svendsen;Urol Oncol,2022

3. Carcinogen biomarkers in the urine of electronic cigarette users and implications for the development of bladder cancer: a systematic review;Bjurlin;Eur Urol Oncol,2021

4. Alternative tobacco products use and its impact on urologic health — will the lesser evil still be evil? A commentary and review of literature;Bjurlin;Cent Eur J Urol,2021

5. Long-term ambient hydrocarbon exposure and incidence of urinary bladder cancer;Zhang;Sci Rep,2022

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors Associated with Urothelial Bladder Cancer;International Journal of Environmental Research and Public Health;2024-07-22

2. Re: Steven Monda, Manolis Pratsinis, Hansen Lui, et al. Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery. Eur Urol Focus. In press. http://doi.org/10.1016/j.euf.2023.09.002;European Urology Focus;2024-04

3. From TURP to enucleation: navigating the complex relationship between BPH treatments and bladder cancer;World Journal of Urology;2024-03-29

4. Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p/LRIG1 axis in bladder carcinoma;Biology Direct;2024-03-07

5. Re: Christopher D. Gaffney, Andrew Katims, Neeta D’Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575–8;European Urology Focus;2024-03